Zevra Therapeutics, Inc. · NASDAQ:ZVRA
Adage Capital Management, L.P.'s stake in Zevra Therapeutics, Inc. fell to 3.96% (Schedule 13G/A)
Event Sep 30, 2025 · Filed Nov 13, 2025
Adage Capital Management, L.P.'s stake in Zevra Therapeutics, Inc. fell to 3.96%, 2,225,000 shares, as a passive investor on Sep 30, 2025. Filed Nov 13, 2025 (Schedule 13G/A).
- Stake
- 3.96%
- Shares
- 2,225,000
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Adage Capital Management, L.P. | 3.96% | 2,225,000 |
| Robert Atchinson | 3.96% | 2,225,000 |
| Phillip Gross | 3.96% | 2,225,000 |
Source
Related
- Zevra Therapeutics, Inc.
- Adage Capital Management, L.P.
- Zevra Therapeutics, Inc. shareholders
- Schedule 13G · Adage Capital Management, L.P. · Feb 12, 2025
- Form 4 · McFarlane Neil F. · Oct 13, 2026
- Form 4 · Thompson Rahsaan · Aug 17, 2026
- Schedule 13G/A · Woodline Partners LP · Aug 14, 2026
- Form 4 · Watton Corey Michael · Aug 12, 2026
- Schedule 13G/A · FMR LLC · Aug 6, 2026